Over a month ago |
Downgrade
|
Morgan Stanley analyst… Morgan Stanley analyst James Faucette downgraded nCino (NCNO) to Equal Weight from Overweight with a price target of $25, down from $27. Beyond medium-term revenue risk from SVB Financial (SIVB) and Signature Bank (SBNY), the analyst expects challenging end market dynamics to weigh on nCino's fiscal half of fiscal 2024 bookings performance and ultimately its fiscal 2025 results. The stock's risk/reward seems balanced when accounting for these risks, which are "likely to remain outstanding beyond our time horizon," the analyst tells investors in a research note. ShowHide Related Items >><< - 03/31/23
- First Citizens reports FDIC exercises $500M appreciation right in SVB deal
- 03/27/23
- FDIC investigating misconduct in management of SVB Financial, Signature Bank
- 03/27/23
- First Citizens 'encouraged' by SVB's strong underwriting
- 03/27/23
- First Citizens: Capital ratios remains robust after SVB pact
- 04/03/23
- Coinbase lists Signature Bank as option for customer funds
- 03/22/23
- Senators Scott, Warren unveil bipartisan Fed oversight legislation
- 03/22/23
- Stronghold Digital reports no direct exposure to SVB, Signature, Silvergate
- 02/28/23
- nCino selected by JFG to modernize multiple lines of business
- 02/22/23
- nCino's SimpleNexus announces Avidia Bank implemented Nexus Closing
- 02/13/23
- nCino says DOJ investigation closed, no fines or penalties imposed
- 02/07/23
- nCino expands nCino IQ offerings through partnership with rich data company
- 03/29/23 Stephens
- nCino price target lowered to $27 from $33 at Stephens
- 03/29/23 Needham
- nCino price target lowered to $33 from $35 at Needham
- 03/29/23 Truist
- nCino price target lowered to $40 from $45 at Truist
- 03/29/23 BofA
- nCino price target lowered to $30 from $32 at BofA
- 03/29/23 RBC Capital
- Sunrun price target lowered to $34 from $42 at RBC Capital
- 03/28/23 DA Davidson
- First Citizens price target raised to $1,025 from $825 at DA Davidson
- 03/24/23 Morgan Stanley
- nCino price target lowered to $27 from $35 at Morgan Stanley
- 03/23/23 Raymond James
- Block short report doesn't include 'bombshell,' says Raymond James
- 04/03/23 BofA
- New York Community Bancorp price target raised to $10 from $8 at BofA
- 04/03/23 Mizuho
- Mizuho does not know portion of Coinbase funds held at Signature
- 03/22/23 BofA
- Regional bank distress gives CME Group a new growth opportunity, says BofA
- 03/10/23
- Compugen considers exposure to SVB Financial as immaterial
- 01/19/23
- SVB Financial reports Q4 EPS $4.62, consensus $5.27
- 10/20/22
- SVB Financial reports Q3 EPS $7.21, consensus $6.95
- 01/17/23
- Signature Bank reports Q4 EPS $4.65, consensus $4.89
- 10/18/22
- Signature Bank reports Q3 EPS $5.57, consensus $5.41
- 10/17/22
- Notable companies reporting before tomorrow's open
- 03/28/23
- nCino reports Q4 EPS 4c, consensus (5c)
- 01/19/23
- nCino backs FY23 EPS view of (15c)-(17c), consensus (16c)
- 01/19/23
- nCino backs Q4 EPS view of (4c)-(5c), consensus (5c)
- 11/30/22
- nCino raises FY23 EPS view to (17c)-(15c) from (19c)-(17c), consensus (17c)
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 03/06/23
- Urban Outfitters COO Conforti sells 42,000 common shares
- 02/28/23
- Urban Outfitters says Q1 revenue growth could be 'similar to Q4'
- 02/28/23
- Urban Outfitters reports comparable retail segment sales up 3%
- 01/09/23
- Urban Outfitters reports holiday sales increased 2.3%
- 03/20/23
- UBS rises 7.9%
- 03/19/23
- Fly Intel: Top five weekend stock stories
- 03/29/23
- Nano Dimension increases offer to acquire Stratasys to $19.55 per share
- 03/23/23
- Nano Dimension to review options relative to Stratasys and alternative targets
- 03/22/23
- Stratasys up 4.5% at $15.25 as its board rejects Nano Dimension offer
- 03/22/23
- Stratasys board unanimously rejects acquisition proposal from Nano Dimension
- 03/13/23
- SomaLogic delivers 28M proteomic data points on CKB samples
- 01/05/23
- Cathie Wood's ARK Investment bought 415.4K shares of SomaLogic today
- 01/04/23
- Cathie Wood's ARK Investment bought 313K shares of SomaLogic today
- 01/03/23
- Cathie Wood's ARK Investment bought 288K shares of SomaLogic today
- 02/27/23
- Sharecare expands home offerings beyond Medicare Advantage
- 11/17/22
- Ross Stores jumps 15% to $112.50 after Q3 results beat, FY22 EPS view raised
- 11/14/22
- Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3
- 10/16/22
- Fly Intel: Top five weekend stock stories
- 03/23/23
- Progress Software offers free training, certification for Progress OpenEdge
- 02/07/23
- Progress Software completes acquisition of MarkLogic
- 01/19/23
- Progress Software releases Progress Telerik, Progress Kendo UI
- 01/03/23
- Progress Software to acquire MarkLogic for $355M
- 03/28/23
- Dave & Buster's says Q1 QTD SSS roughly flat to down very low single digits
- 03/28/23
- Dave & Buster's announces $100M share repurchase program
- 02/07/23
- Dave & Buster's: Dave & Buster's World opens virtual doors on Roblox
- 12/06/22
- Dave & Buster's provides Q4 business update
- 03/27/23
- Nano Dimension files lawsuit against Murchinson, Anson and Boothbay
- 03/27/23
- Nano Dimension announces purchase order from Fraunhofer Institue
- 02/28/23
- nCino selected by JFG to modernize multiple lines of business
- 02/22/23
- nCino's SimpleNexus announces Avidia Bank implemented Nexus Closing
- 02/13/23
- nCino says DOJ investigation closed, no fines or penalties imposed
- 02/07/23
- nCino expands nCino IQ offerings through partnership with rich data company
- 03/28/23
- Micron says now expects overall headcount reduction to approach 15%
- 03/28/23
- Micron says further reducing supply
- 03/28/23
- Micron up 2% after Q2 report
- 03/02/23
- Micron down 3% in pre-market as CFO presents at conference
- 03/29/23
- Macy's announces CFO Adrian Mitchell to assume COO role as well
- 03/29/23
- Macy's CEO Jeff Gennette to retire, Tony Spring to succeed
- 03/14/23
- Macy's launches expanded Reebok assortment in stores, online
- 03/02/23
- Macy's rises 10.0%
- 03/27/23
- Lyft announces CEO succession plan, appoints David Risher next CEO
- 03/14/23
- California court upholds treating Uber, Lyft drivers as contractors
- 02/16/23
- Lyft announces Alicia Zuiker joining as Chief People Officer
- 02/09/23
- Lyft says focus on growth will be centered around Pink
- 12/29/22
- Kingsoft Cloud announces results of extraordinary general meeting
- 12/27/22
- China stocks rising with borders set to reopen on January 8
- 12/23/22
- PCAOB chair 'applauds' Congressional action to shorten HFCAA timeline
- 03/26/23
- Fly Intel: Top five weekend stock stories
- 03/22/23
- JPMorgan to acquire Aumni, terms not disclosed
- 03/21/23
- Campbell Lutyens and J.P. Morgan announce collaboration in 2NDRY advisory market
- 03/24/23
- Illumina says Icahn nominees 'lack relevant skills and experience'
- 03/24/23
- Icahn to investigate 'massive value destruction' by Illumina
- 03/20/23
- Illumina says Icahn's nominees 'lack relevant skills and experience'
- 03/15/23
- Icahn says 'only path forward' for Illumina is to divest GRAIL
- 02/21/23
- Bath & Body Works appoints Hershey CFO Voskuil to board
- 12/07/22
- Hershey announces first bilingual manufacturing facility
- 10/20/22
- Hershey signs new solar power purchase agreement with National Grid Renewables
- 03/27/23
- First Republic rises 15.5%
- 03/27/23
- First Republic rises 22.8%
- 03/27/23
- First Republic rises 25.0%
- 03/20/23
- Foot Locker focusing on banners, geographies that will drive growth, says CEO
- 03/20/23
- Foot Locker to close stores, ecommerce in Hong Kong, Macau
- 11/29/22
- Foot Locker announces leadership team appointments
- 11/18/22
- Foot Locker rises 14.7%
EBS Emergent BioSolutions - 03/29/23
- Emergent says over-the-counter Narcan will be available by late summer
- 03/29/23
- Emergent BioSolutions: FDA approves OTC designation for Narcan Nasal Spray
- 03/29/23
- Emergent BioSolutions rises 17.5%
- 03/29/23
- Emergent jumps 19% to $10.60 after FDA approves over-the-counter Narcan
- 03/05/23
- Fly Intel: Top five weekend stock stories
- 02/22/23
- Deere raises dividend to $1.25 from $1.20 per share
- 02/17/23
- Deere sees raw material costs getting more favorable throughout 2023
- 02/17/23
- Deere doesn't see big increase in dealier inventory in 2023
- 03/29/23
- UBS board names Sergio Ermotti as new group CEO, effective April 5
- 03/27/23
- Invesco Mortgage says no direct counterparty exposure to Credit Suisse
- 03/21/23
- Chubb says does not have exposure to any Credit Suisse AT1 bonds
- 03/20/23
- S&P revises UBS Group outlook to Negative, affirms ratings
- 03/29/23
- Conn's down 1% to $5.35 as earnings call continues
- 03/29/23
- Conn's CEO says total retail sales down 18.6% in Q1-to-date
- 03/29/23
- Conn's plans to open 11 new standalone locations in FY24
- 01/10/23
- Conn's extending gains afterhours on WSJ report of acquisition interest, up 13%
- 03/06/23
- Ciena expects to repurchase $250M shares this FY
- 03/06/23
- Ciena sees inventory lower in 4Q23 vs. 4Q22
- 03/06/23
- Ciena on track to achieve three year revenue CAGR outlook of 10%-12%, says CEO
- 03/06/23
- Ciena CEO: WaveLogic 6 to support up to 1.6Tbps single carrier wavelengths
- 03/27/23
- Carnival CEO says 'well booked for the remainder of the year at higher prices'
- 03/27/23
- Carnival ends Q1 with $8.1B of liquidity
- 01/27/23
- Salesforce appoints three new independent directors to board
- 01/18/23
- Carnival expands next-generation wi-fi connectivity with SpaceX's Starlink
- 03/28/23
- Cal-Maine Foods says current HPAI epidemic surpassed prior outbreak in duration
- 03/27/23
- Cal-Maine Foods names Todd Walters COO
- 02/06/23
- Reed asked FTC to crack down on possible egg price gouging
- 01/19/23
- Cal-Maine Foods in partnership with Entegrity to install solar array
- 03/06/23
- Cardinal Health, Signify Health collaborate on in-home health management
- 02/16/23
- Cardinal Health, RxLive collaborate to enhance connectivity between providers
- 12/19/22
- Cardinal Health announces Aaron Alt as chief financial officer
- 12/12/22
- Yellow Corp appoints Annlea Rumfola as CIO
- 11/22/22
- Burlington Stores rises 14.5%
- 11/22/22
- Burlington Stores rises 16.8%
- 11/22/22
- Burlington Stores rises 17.0%
- 11/22/22
- Burlington Stores CEO: 'We think the outlook for 2023 is very positive'
- 01/18/23
- Bluebird Bio falls 14% to $6.28 after 20M share offering of common stock
- 01/06/23
- Bluebird Bio to sell second Zynteglo PRV for $95M
- 01/03/23
- Bluebird Bio appoints Joseph Vittiglio, JD, chief business and legal officer
- 12/29/22
- Bluebird Bio completes sale pf PRV to Argenx
ARCT Arcturus Therapeutics - 03/29/23
- Arcturus Therapeutics says cash runway now extends to 2026
- 01/31/23
- Arcturus: New Zealand approves clinical trial application for ARCT-032 for CF
- 12/12/22
- CSL announces closing of global collaboration with Arcturus Therapeutics
- 11/01/22
- Arcturus Therapeutics announces collaboration with CSL Seqirus
- 03/29/23 Needham
- Micron price target raised to $71 from $67 at Needham
- 03/29/23 Susquehanna
- Micron price target raised to $90 from $65 at Susquehanna
- 03/29/23 TD Cowen
- Micron price target raised to $70 from $66 at TD Cowen
- 03/29/23 Baird
- Micron price target raised to $60 from $45 at Baird
- 03/29/23
- Gordon Haskett downgrades Macy's on moderating foot traffic trends
- 03/29/23
- Macy's downgraded to Hold from Accumulate at Gordon Haskett
- 03/03/23 TD Cowen
- Macy's price target raised to $29 from $27 at TD Cowen
- 02/23/23 Citi
- Macy's price target raised to $23 from $22 at Citi
- 03/29/23 RBC Capital
- Sunrun price target lowered to $34 from $42 at RBC Capital
- 03/24/23 Jefferies
- UBS downgraded to Hold from Buy at Jefferies
- 03/20/23 Barclays
- European Banks sector view downgraded to Neutral at Barclays
- 03/20/23 Societe Generale
- UBS downgraded to Hold from Buy at Societe Generale
- 03/29/23 RBC Capital
- UBS downgraded to Sector Perform from Outperform at RBC Capital
- 03/27/23 Citi
- UBS price target raised to CHF 26 from CHF 24 at Citi
- 03/26/23 Citi
- UBS price target raised to CHF 26 from CHF 24 at Citi
- 03/10/23 Lake Street
- Nano Dimension made 'lowball offer' Stratasys won't accept, says Lake Street
- 03/03/23 Lake Street
- Stratasys price target raised to $22 from $20 at Lake Street
- 01/04/23 Needham
- Needham upgrades Stratasys to Buy, sees valuation reflect more challenging 2023
- 01/04/23 Needham
- Stratasys upgraded to Buy from Hold at Needham
- 03/22/23 Deutsche Bank
- Cardinal Health price target lowered to $77 from $82 at Deutsche Bank
- 02/03/23 Baird
- Baird upgrades Cardinal Health, sees 'value trap label' ending
- 02/03/23 Baird
- Cardinal Health upgraded to Outperform from Neutral at Baird
- 01/31/23 UBS
- Cardinal Health price target raised to $91 from $78 at UBS
- 03/13/23 Piper Sandler
- Piper agrees with Icahn, says Illumina base business undervalued
- 02/14/23 UBS
- Illumina price target lowered to $240 from $255 at UBS
- 02/08/23 Stifel
- Illumina price target lowered to $235 from $285 at Stifel
- 02/08/23 RBC Capital
- Illumina price target raised to $303 from $284 at RBC Capital
- 03/28/23 Deutsche Bank
- Lyft CEO change 'opens the door' for potential buyout, says Deutsche Bank
- 03/28/23 Wedbush
- Wedbush incrementally more positive on Lyft with 'CEO changing of guard'
- 03/15/23 Deutsche Bank
- Lyft price target raised to $12 from $11 at Deutsche Bank
- 03/14/23 Jefferies
- California ruling a 'big win' for Uber, Lyft and DoorDash, says Jefferies
- 03/24/23 RBC Capital
- JPMorgan price target lowered to $132 from $150 at RBC Capital
- 03/13/23 Wells Fargo
- Wells Fargo upgrades JPMorgan on 'Goliath is Winning' theme
- 03/13/23 Wells Fargo
- JPMorgan upgraded to Overweight from Equal Weight at Wells Fargo
- 02/24/23 Morgan Stanley
- JPMorgan price target raised to $173 from $167 at Morgan Stanley
- 03/23/23 Citi
- Citi withdraws Neutral rating on First Republic
- 03/21/23 Goldman Sachs
- First Republic rating suspended at Goldman Sachs
- 03/20/23 Evercore ISI
- Evercore ISI suspends rating on First Republic in light of uncertainty
- 03/20/23 Morgan Stanley
- Morgan Stanley removes First Republic price target amid 'wide range of outcomes'
ARCT Arcturus Therapeutics - 11/14/22 Wells Fargo
- Arcturus Therapeutics resumed with an Overweight at Wells Fargo
- 11/10/22 Baird
- Arcturus Therapeutics downgraded to Underperform from Neutral at Baird
- 11/03/22 Citi
- Arcturus Therapeutics upgraded to Buy at Citi after CSL deal
- 11/03/22 Citi
- Arcturus Therapeutics upgraded to Buy from Neutral at Citi
EBS Emergent BioSolutions - 03/17/23 JPMorgan
- Emergent BioSolutions downgraded to Underweight from Neutral at JPMorgan
- 12/28/22 Benchmark
- Benchmark keeps Hold on Emergent after non-profit OTC naloxone competitor news
- 11/10/22 Benchmark
- Benchmark downgrades Emergent on delay in smallpox vaccine fulfillment
- 11/10/22 Benchmark
- Emergent BioSolutions downgraded to Hold from Buy at Benchmark
- 03/13/23 JPMorgan
- Kingsoft Cloud initiated with a Neutral at JPMorgan
- 01/09/23 China Renaissance
- Kingsoft Cloud downgraded to Sell from Hold at China Renaissance
- 09/07/22 Citi
- Kingsoft Cloud downgraded to Neutral from Buy at Citi
- 06/09/22 Citi
- Kingsoft Cloud price target lowered to $8.50 from $10 at Citi
- 03/29/23 Raymond James
- Bluebird Bio reaction to lovo-cel BLA delay 'overdone,' says Raymond James
- 03/06/23 Baird
- Baird starts Bluebird at Outperform, sees lovo-cel beating estimates
- 03/06/23 Baird
- Bluebird Bio initiated with an Outperform at Baird
- 12/19/22 Morgan Stanley
- FDA removing lovo-cel partial hold a positive for Bluebird, says Morgan Stanley
- 01/03/23 BTIG
- Sharecare named Top Pick for first half of 2023 at BTIG
- 11/11/22 Canaccord
- Sharecare price target lowered to $3 from $4 at Canaccord
- 11/11/22 Canaccord
- Sharecare price target lowered to $3 from $4 at Canaccord
- 10/19/22 BTIG
- Sharecare 'obvious beneficiary' of Elevance growth, says BTIG
- 03/29/23 Canaccord
- SomaLogic price target lowered to $5 from $6 at Canaccord
- 03/29/23 TD Cowen
- SomaLogic price target lowered to $7 from $8 at TD Cowen
- 03/29/23 Stifel
- SomaLogic price target lowered to $7 from $8 at Stifel
- 08/16/22 TD Cowen
- SomaLogic price target lowered to $9 from $11 at Cowen
- 03/29/23 Susquehanna
- Susquehanna upgrades Carnival with liquidity concerns 'effectively de-risked'
- 03/29/23 Susquehanna
- Carnival upgraded to Positive from Neutral at Susquehanna
- 03/28/23 Stifel
- Stifel believes setup for Carnival's shares is 'overly compelling'
- 03/28/23 Barclays
- Carnival price target raised to $13 from $12 at Barclays
- 03/29/23 Wells Fargo
- Hershey upgraded to Equal Weight on pricing tailwinds at Wells Fargo
- 03/29/23 Wells Fargo
- Hershey upgraded to Equal Weight from Underweight at Wells Fargo
- 03/27/23 Mizuho
- Hershey price target raised to $235 from $222 at Mizuho
- 03/23/23 Evercore ISI
- Hershey price target raised to $255 from $250 at Evercore ISI
- 03/29/23 UBS
- Foot Locker downgraded to Sell at UBS on softlines bearishness
- 03/29/23 UBS
- Foot Locker downgraded to Sell from Neutral at UBS
- 03/21/23 Deutsche Bank
- Foot Locker price target raised to $42 from $36 at Deutsche Bank
- 03/21/23 Morgan Stanley
- Morgan Stanley 'skeptical' of 'show-me' story Foot Locker's long-term targets
- 03/29/23 UBS
- Urban Outfitters downgraded to Sell at UBS on softlines bearishness
- 03/29/23 UBS
- Urban Outfitters downgraded to Sell from Neutral at UBS
- 03/02/23 Barclays
- Urban Outfitters price target raised to $29 from $27 at Barclays
- 03/01/23 Deutsche Bank
- Deutsche Bank keeps Hold rating on Urban Outfitters, raises price target to $27
- 03/29/23 UBS
- Burlington Stores downgraded to Sell at UBS on softlines bearishness
- 03/29/23 UBS
- Burlington Stores downgraded to Sell from Neutral at UBS
- 03/03/23 Deutsche Bank
- Burlington Stores price target raised to $235 from $214 at Deutsche Bank
- 03/03/23 Morgan Stanley
- Burlington Stores price target raised to $233 from $219 at Morgan Stanley
- 03/29/23 UBS
- Ross Stores downgraded to Sell at UBS on softlines bearishness
- 03/29/23 UBS
- Ross Stores downgraded to Sell from Neutral at UBS
- 03/22/23 Loop Capital
- Loop upgrades Ross Stores to Buy on steady spending, conservative outlook
- 03/22/23 Loop Capital
- Ross Stores upgraded to Buy from Hold at Loop Capital
- 03/29/23 Morgan Stanley
- Ciena downgraded to Equal Weight from Overweight at Morgan Stanley
- 03/28/23 Raymond James
- Ciena added to Analyst Current Favorites List at Raymond James
- 03/28/23 Raymond James
- Ciena upgraded to Strong Buy from Outperform at Raymond James
- 03/07/23 B. Riley
- Ciena price target raised to $72 from $69 at B. Riley
- 03/29/23 Daiwa
- Deere initiated with an Outperform at Daiwa
- 03/29/23 Daiwa
- Deere initiated with an Outperform at Daiwa
- 02/21/23 Argus
- Deere price target raised to $485 from $475 at Argus
- 02/21/23 Morgan Stanley
- Deere price target raised to $537 from $522 at Morgan Stanley
- 03/24/23 Lake Street
- Vital Farms initiated with a Buy at Lake Street
- 12/29/22 BofA
- Cal-Maine earnings miss to weigh on shares, says BofA
- 09/28/22 BofA
- Cal-Maine Foods price target lowered to $50 from $55 at BofA
- 03/30/22 Consumer Edge
- Cal-Maine Foods upgraded to Overweight from Equal Weight at Consumer Edge
- 03/29/23 Stephens
- nCino price target lowered to $27 from $33 at Stephens
- 03/29/23 Needham
- nCino price target lowered to $33 from $35 at Needham
- 03/29/23 Truist
- nCino price target lowered to $40 from $45 at Truist
- 03/29/23 BofA
- nCino price target lowered to $30 from $32 at BofA
- 03/29/23 Truist
- Dave & Buster's price target lowered to $60 from $62 at Truist
- 03/14/23 Truist
- Truist card transaction data bullish for fast-food restaurant demand
- 12/21/22 Jefferies
- Brinker downgraded to Hold from Buy at Jefferies
- 12/08/22 Loop Capital
- Dave & Buster's off to slow start in Q4, says Loop Capital
- 03/29/23 Oppenheimer
- Progress Software price target raised to $63 from $53 at Oppenheimer
- 03/13/23 Guggenheim
- Progress Software price target raised to $64 from $60 at Guggenheim
- 03/12/23 Citi
- Citi not too concerned about systems software exposure to SVB
- 01/23/23 Guggenheim
- Progress Software assumed with a Buy at Guggenheim
- 12/07/22 Stephens
- Conn's price target lowered to $9 from $13 at Stephens
- 04/11/22 Stephens
- Conn's assumed with an Equal Weight at Stephens
- 02/28/23
- Urban Outfitters reports Q4 EPS 34c, consensus 38c
- 11/21/22
- Urban Outfitters reports Q3 EPS 40c, consensus 42c
- 11/21/22
- Notable companies reporting after market close
- 01/31/23
- UBS reports Q4 EPS 50c, profit before tax $1.9B
- 10/25/22
- UBS reports Q3 EPS 52c, net profit $1.7B
- 03/02/23
- Stratasys sees FY23 EPS 12c-24c, consensus 20c
- 03/02/23
- Stratasys reports Q4 EPS 7c, consensus 3c
- 11/10/22
- Stratasys sees FY22 EPS 9c-12c, consensus 14c
- 03/28/23
- SomaLogic sees FY23 revenue $80M-$84M, consensus $92.75M
- 03/28/23
- SomaLogic reports Q4 EPS (26c), consensus (21c)
- 01/09/23
- SomaLogic sees 2022 revenue at high-end of $93M-$98M, consensus $95M
- 11/14/22
- SomaLogic sees FY22 revenue $93M-$98M, consensus $83.02M
- 03/29/23
- Sharecare sees FY23 revenue $450M-$460M, consensus $518.49M
- 03/29/23
- Sharecare sees Q1 revenue $111M-$113M, consensus $118.8M
- 03/29/23
- Sharecare reports Q4 adjusted EPS (2c), consensus (5c)
- 11/10/22
- Sharecare reports Q3 adjusted EPS (1c), consensus (6c)
- 02/28/23
- Ross Stores sees FY23 EPS $4.65-$4.95, consensus $5.09
- 02/28/23
- Ross Stores sees Q1 EPS 99c-$1.05, consensus $1.18
- 02/28/23
- Ross Stores reports Q4 EPS $1.31, consensus $1.24
- 02/28/23
- Notable companies reporting after market close
- 03/28/23
- Progress Software sees Q2 EPS 88c-92c, consensus 99c
- 03/28/23
- Progress Software backs FY23 EPS view $4.09-$4.17, consensus $4.14
- 03/28/23
- Progress Software reports Q1 EPS $1.19, consensus $1.05
- 01/17/23
- Progress Software sees FY23 EPS $4.09 - $4.17 , consensus $4.35
- 03/28/23
- Dave & Buster's reports Q4 EPS 80c, consensus 73c
- 12/06/22
- Dave & Buster's reports Q3 EPS 4c, consensus 4c
- 01/24/23
- Nano Dimension reports Q4 revenue $12.1M, up 61% vs. 4Q21
- 12/01/22
- Nano Dimension reports Q3 EPS (26c) vs. (7c) last year
- 10/24/22
- Nano Dimension sees Q3 revenue $10M
- 03/28/23
- nCino reports Q4 EPS 4c, consensus (5c)
- 01/19/23
- nCino backs FY23 EPS view of (15c)-(17c), consensus (16c)
- 01/19/23
- nCino backs Q4 EPS view of (4c)-(5c), consensus (5c)
- 11/30/22
- nCino raises FY23 EPS view to (17c)-(15c) from (19c)-(17c), consensus (17c)
- 03/28/23
- Micron sees Q3 adjusted EPS ($1.65)-($1.51), consensus (90c)
- 03/28/23
- Micron reports Q2 adjusted EPS ($1.91), consensus (86c)
- 03/28/23
- Notable companies reporting after market close
- 03/02/23
- Micron sees lower margins in fiscal Q3 than previously expected
- 03/02/23
- Macy's sees Q1 adjusted EPS 42c-48c, consensus 72c
- 03/02/23
- Macy's sees FY23 adjusted EPS $3.67-$4.11, consensus $3.84
- 03/02/23
- Macy's reports Q4 adjusted EPS $1.88, consensus $1.57
- 03/01/23
- Notable companies reporting before tomorrow's open
- 02/09/23
- Lyft reports Q4 active riders up 8.7% y/y
- 02/09/23
- Lyft sees Q1 revenue roughly $975M, consensus $1.09B
- 02/09/23
- Lyft reports Q4 adjusted EBITDA ($248.3M) vs ($47.6M) last year
- 02/09/23
- Notable companies reporting after market close
- 03/29/23
- Kingsoft Cloud sees Q1 revenue RMB1.85B-RMB2.05B
- 03/29/23
- Kingsoft Cloud reports Q4 EPS (2c), consensus (24c)
- 11/23/22
- Kingsoft Cloud sees Q4 revenue up 1.6%-11.7% sequentially to RMB2.0B-RMB2.2B
- 11/23/22
- Kingsoft Cloud reports Q3 EPS (3c), consensus (23c)
- 01/13/23
- JPMorgan reports Q4 EPS $3.57, consensus $3.07
- 01/12/23
- Notable companies reporting before tomorrow's open
- 10/14/22
- JPMorgan reports Q3 EPS $3.12, consensus $2.88
- 02/07/23
- Illumina sees FY23 adjusted EPS $1.25-$1.50, consensus $1.98
- 02/07/23
- Illumina reports Q4 adjusted EPS 14c, consensus 10c
- 02/07/23
- Notable companies reporting after market close
- 11/03/22
- Illumina sees FY22 adjusted EPS $2.35-$2.50, consensus $2.78
- 03/22/23
- Hershey backs FY23 adjusted EPS growth view 9%-11%, consensus $9.35
- 02/02/23
- Hershey sees FY23 adjusted EPS up 9%-11%, consensus $8.94
- 02/02/23
- Hershey reports Q4 adjusted EPS $2.02, consensus $1.77
- 01/13/23
- First Republic reports Q4 EPS $1.88, consensus $1.80
- 10/14/22
- First Republic reports Q3 EPS $2.21, consensus $2.18
- 03/20/23
- Foot Locker targeting adjusted EPS growth in low to mid 20% range for FY24-FY26
- 03/20/23
- Foot Locker sees FY23 adjusted EPS $3.35-$3.65, consensus $4.48
- 03/20/23
- Foot Locker reports Q4 adjusted EPS 97c, consensus 51c
- 11/18/22
- Foot Locker raises FY22 EPS view to $4.42-$4.50 from $4.25-$4.45
EBS Emergent BioSolutions - 02/27/23
- Emergent BioSolutions sees FY23 revenue $1.1B-$1.2B, consensus $1.18B
- 02/27/23
- Emergent BioSolutions sees Q1 revenue $130M-$150M, consensus $245.9M
- 02/27/23
- Emergent BioSolutions reports Q4 EPS (31c), consensus 4c
- 01/09/23
- Emergent reports preliminary FY22 revenue $1.1B-$1.12B, consensus $1.09B
- 02/17/23
- Deere sees FY23 net income $8.75B-$9.25B, effective tax rate 23%-25%
- 02/17/23
- Deere reports Q1 EPS $6.55, consensus $5.56
- 02/16/23
- Notable companies reporting before tomorrow's open
- 02/09/23
- Credit Suisse reports Q4 net revenue CHF 3.06B vs. CHF 4.58B last year
- 10/27/22
- Credit Suisse reports Q3 net revenue CHF 3.8B vs. CHF 5.43B last year
- 03/29/23
- Conn's reports Q4 adjusted EPS ($1.53), consensus (87c)
- 12/06/22
- Conn's reports Q3 non-GAAP EPS (78c), consensus (83c)
- 10/18/22
- Conn's withdraws FY23 financial guidance
- 10/18/22
- Conn's sees Q3 revenue down 21%-23%, consensus $326.11M
- 03/06/23
- Ciena now sees FY23 revenue up 20%-22% y/y, up from 16%-18% y/y
- 03/06/23
- Ciena sees Q2 revenue $1.035B-$1.115B, consensus $1.04B
- 03/06/23
- Ciena reports Q1 adjusted EPS 64c, consensus 36c
- 12/08/22
- Ciena sees Q1 revenue $910M-$990M, consensus $871.03M
- 03/27/23
- Carnival sees Q2 adjusted EBITDA $600M-$700M
- 03/27/23
- Carnival sees FY23 adjusted EBITDA $3.9B-$4.1B
- 03/27/23
- Carnival sees FY23 adjusted EPS (44c)-(28c), consensus (8c)
- 03/27/23
- Carnival sees Q2 adjusted EPS (42c)-(34c), consensus (28c)
- 03/28/23
- Cal-Maine Foods reports Q3 EPS $6.62, consensus $5.47
- 12/28/22
- Cal-Maine Foods reports Q2 EPS $4.07, consensus $4.24
- 02/02/23
- Cardinal Health raises FY23 EPS view to $5.20-$5.50 from $5.05-$5.40
- 02/02/23
- Cardinal Health reports Q2 EPS $1.32, consensus $1.14
- 02/01/23
- Notable companies reporting before tomorrow's open
- 03/02/23
- Burlington Stores sees Q1 adjusted EPS 85c-95c, consensus 82c
- 03/02/23
- Burlington Stores sees FY23 adjusted EPS $5.50-$6.00, consensus $6.65
- 03/02/23
- Burlington Stores reports Q4 adjusted EPS $2.96, consensus $2.73
- 03/29/23
- Bluebird Bio reports Q4 EPS (38c), consensus (44c)
- 11/07/22
- Bluebird Bio reports Q4 EPS (94c) vs, ($3.16)
- 11/07/22
- Bluebird Bio reports Q4 EPS (94c) vs, ($3.16)
ARCT Arcturus Therapeutics - 03/28/23
- Arcturus Therapeutics reports Q4 EPS $4.33, consensus 98c
- 11/09/22
- Arcturus Therapeutics reports Q3 EPS ($1.33), consensus ($1.81)
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 03/06/23
- Urban Outfitters COO Conforti sells 42,000 common shares
- 02/28/23
- Urban Outfitters says Q1 revenue growth could be 'similar to Q4'
- 02/28/23
- Urban Outfitters reports comparable retail segment sales up 3%
- 01/09/23
- Urban Outfitters reports holiday sales increased 2.3%
- 03/20/23
- UBS rises 7.9%
- 03/19/23
- Fly Intel: Top five weekend stock stories
- 03/29/23
- Nano Dimension increases offer to acquire Stratasys to $19.55 per share
- 03/23/23
- Nano Dimension to review options relative to Stratasys and alternative targets
- 03/22/23
- Stratasys up 4.5% at $15.25 as its board rejects Nano Dimension offer
- 03/22/23
- Stratasys board unanimously rejects acquisition proposal from Nano Dimension
- 03/13/23
- SomaLogic delivers 28M proteomic data points on CKB samples
- 01/05/23
- Cathie Wood's ARK Investment bought 415.4K shares of SomaLogic today
- 01/04/23
- Cathie Wood's ARK Investment bought 313K shares of SomaLogic today
- 01/03/23
- Cathie Wood's ARK Investment bought 288K shares of SomaLogic today
- 02/27/23
- Sharecare expands home offerings beyond Medicare Advantage
- 11/17/22
- Ross Stores jumps 15% to $112.50 after Q3 results beat, FY22 EPS view raised
- 11/14/22
- Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3
- 10/16/22
- Fly Intel: Top five weekend stock stories
- 03/23/23
- Progress Software offers free training, certification for Progress OpenEdge
- 02/07/23
- Progress Software completes acquisition of MarkLogic
- 01/19/23
- Progress Software releases Progress Telerik, Progress Kendo UI
- 01/03/23
- Progress Software to acquire MarkLogic for $355M
- 03/28/23
- Dave & Buster's says Q1 QTD SSS roughly flat to down very low single digits
- 03/28/23
- Dave & Buster's announces $100M share repurchase program
- 02/07/23
- Dave & Buster's: Dave & Buster's World opens virtual doors on Roblox
- 12/06/22
- Dave & Buster's provides Q4 business update
- 03/27/23
- Nano Dimension files lawsuit against Murchinson, Anson and Boothbay
- 03/27/23
- Nano Dimension announces purchase order from Fraunhofer Institue
- 02/28/23
- nCino selected by JFG to modernize multiple lines of business
- 02/22/23
- nCino's SimpleNexus announces Avidia Bank implemented Nexus Closing
- 02/13/23
- nCino says DOJ investigation closed, no fines or penalties imposed
- 02/07/23
- nCino expands nCino IQ offerings through partnership with rich data company
- 03/28/23
- Micron says now expects overall headcount reduction to approach 15%
- 03/28/23
- Micron says further reducing supply
- 03/28/23
- Micron up 2% after Q2 report
- 03/02/23
- Micron down 3% in pre-market as CFO presents at conference
- 03/29/23
- Macy's announces CFO Adrian Mitchell to assume COO role as well
- 03/29/23
- Macy's CEO Jeff Gennette to retire, Tony Spring to succeed
- 03/14/23
- Macy's launches expanded Reebok assortment in stores, online
- 03/02/23
- Macy's rises 10.0%
- 03/27/23
- Lyft announces CEO succession plan, appoints David Risher next CEO
- 03/14/23
- California court upholds treating Uber, Lyft drivers as contractors
- 02/16/23
- Lyft announces Alicia Zuiker joining as Chief People Officer
- 02/09/23
- Lyft says focus on growth will be centered around Pink
- 12/29/22
- Kingsoft Cloud announces results of extraordinary general meeting
- 12/27/22
- China stocks rising with borders set to reopen on January 8
- 12/23/22
- PCAOB chair 'applauds' Congressional action to shorten HFCAA timeline
- 03/26/23
- Fly Intel: Top five weekend stock stories
- 03/22/23
- JPMorgan to acquire Aumni, terms not disclosed
- 03/21/23
- Campbell Lutyens and J.P. Morgan announce collaboration in 2NDRY advisory market
- 03/24/23
- Illumina says Icahn nominees 'lack relevant skills and experience'
- 03/24/23
- Icahn to investigate 'massive value destruction' by Illumina
- 03/20/23
- Illumina says Icahn's nominees 'lack relevant skills and experience'
- 03/15/23
- Icahn says 'only path forward' for Illumina is to divest GRAIL
- 02/21/23
- Bath & Body Works appoints Hershey CFO Voskuil to board
- 12/07/22
- Hershey announces first bilingual manufacturing facility
- 10/20/22
- Hershey signs new solar power purchase agreement with National Grid Renewables
- 03/27/23
- First Republic rises 15.5%
- 03/27/23
- First Republic rises 22.8%
- 03/27/23
- First Republic rises 25.0%
- 03/20/23
- Foot Locker focusing on banners, geographies that will drive growth, says CEO
- 03/20/23
- Foot Locker to close stores, ecommerce in Hong Kong, Macau
- 11/29/22
- Foot Locker announces leadership team appointments
- 11/18/22
- Foot Locker rises 14.7%
- $13.40 /
+2.165 (+19.27%) - 03/29/23
- Enovix announces manufacturing partner, location for Fab-2 in Malaysia
- 03/20/23
- Enovix director buys $757K in common stock
- 03/15/23
- Enovix director buys $1.35M in common stock
- 03/13/23
- Enovix announces several leadership additions
- 03/05/23
- Fly Intel: Top five weekend stock stories
- 02/22/23
- Deere raises dividend to $1.25 from $1.20 per share
- 02/17/23
- Deere sees raw material costs getting more favorable throughout 2023
- 02/17/23
- Deere doesn't see big increase in dealier inventory in 2023
- 03/29/23
- UBS board names Sergio Ermotti as new group CEO, effective April 5
- 03/27/23
- Invesco Mortgage says no direct counterparty exposure to Credit Suisse
- 03/21/23
- Chubb says does not have exposure to any Credit Suisse AT1 bonds
- 03/20/23
- S&P revises UBS Group outlook to Negative, affirms ratings
- 03/29/23
- Conn's down 1% to $5.35 as earnings call continues
- 03/29/23
- Conn's CEO says total retail sales down 18.6% in Q1-to-date
- 03/29/23
- Conn's plans to open 11 new standalone locations in FY24
- 01/10/23
- Conn's extending gains afterhours on WSJ report of acquisition interest, up 13%
- 03/06/23
- Ciena expects to repurchase $250M shares this FY
- 03/06/23
- Ciena sees inventory lower in 4Q23 vs. 4Q22
- 03/06/23
- Ciena on track to achieve three year revenue CAGR outlook of 10%-12%, says CEO
- 03/06/23
- Ciena CEO: WaveLogic 6 to support up to 1.6Tbps single carrier wavelengths
- 03/27/23
- Carnival CEO says 'well booked for the remainder of the year at higher prices'
- 03/27/23
- Carnival ends Q1 with $8.1B of liquidity
- 01/27/23
- Salesforce appoints three new independent directors to board
- 01/18/23
- Carnival expands next-generation wi-fi connectivity with SpaceX's Starlink
- 03/28/23
- Cal-Maine Foods says current HPAI epidemic surpassed prior outbreak in duration
- 03/27/23
- Cal-Maine Foods names Todd Walters COO
- 02/06/23
- Reed asked FTC to crack down on possible egg price gouging
- 01/19/23
- Cal-Maine Foods in partnership with Entegrity to install solar array
- 03/06/23
- Cardinal Health, Signify Health collaborate on in-home health management
- 02/16/23
- Cardinal Health, RxLive collaborate to enhance connectivity between providers
- 12/19/22
- Cardinal Health announces Aaron Alt as chief financial officer
- 12/12/22
- Yellow Corp appoints Annlea Rumfola as CIO
- 11/22/22
- Burlington Stores rises 14.5%
- 11/22/22
- Burlington Stores rises 16.8%
- 11/22/22
- Burlington Stores rises 17.0%
- 11/22/22
- Burlington Stores CEO: 'We think the outlook for 2023 is very positive'
- 01/18/23
- Bluebird Bio falls 14% to $6.28 after 20M share offering of common stock
- 01/06/23
- Bluebird Bio to sell second Zynteglo PRV for $95M
- 01/03/23
- Bluebird Bio appoints Joseph Vittiglio, JD, chief business and legal officer
- 12/29/22
- Bluebird Bio completes sale pf PRV to Argenx
ARCT Arcturus Therapeutics - 03/29/23
- Arcturus Therapeutics says cash runway now extends to 2026
- 01/31/23
- Arcturus: New Zealand approves clinical trial application for ARCT-032 for CF
- 12/12/22
- CSL announces closing of global collaboration with Arcturus Therapeutics
- 11/01/22
- Arcturus Therapeutics announces collaboration with CSL Seqirus
- 03/29/23 Needham
- Micron price target raised to $71 from $67 at Needham
- 03/29/23 Susquehanna
- Micron price target raised to $90 from $65 at Susquehanna
- 03/29/23 TD Cowen
- Micron price target raised to $70 from $66 at TD Cowen
- 03/29/23 Baird
- Micron price target raised to $60 from $45 at Baird
- 03/29/23
- Gordon Haskett downgrades Macy's on moderating foot traffic trends
- 03/29/23
- Macy's downgraded to Hold from Accumulate at Gordon Haskett
- 03/03/23 TD Cowen
- Macy's price target raised to $29 from $27 at TD Cowen
- 02/23/23 Citi
- Macy's price target raised to $23 from $22 at Citi
- 03/29/23 RBC Capital
- Sunrun price target lowered to $34 from $42 at RBC Capital
- 03/24/23 Jefferies
- UBS downgraded to Hold from Buy at Jefferies
- 03/20/23 Barclays
- European Banks sector view downgraded to Neutral at Barclays
- 03/20/23 Societe Generale
- UBS downgraded to Hold from Buy at Societe Generale
- 03/29/23 RBC Capital
- UBS downgraded to Sector Perform from Outperform at RBC Capital
- 03/27/23 Citi
- UBS price target raised to CHF 26 from CHF 24 at Citi
- 03/26/23 Citi
- UBS price target raised to CHF 26 from CHF 24 at Citi
- 03/10/23 Lake Street
- Nano Dimension made 'lowball offer' Stratasys won't accept, says Lake Street
- 03/03/23 Lake Street
- Stratasys price target raised to $22 from $20 at Lake Street
- 01/04/23 Needham
- Needham upgrades Stratasys to Buy, sees valuation reflect more challenging 2023
- 01/04/23 Needham
- Stratasys upgraded to Buy from Hold at Needham
- 03/22/23 Deutsche Bank
- Cardinal Health price target lowered to $77 from $82 at Deutsche Bank
- 02/03/23 Baird
- Baird upgrades Cardinal Health, sees 'value trap label' ending
- 02/03/23 Baird
- Cardinal Health upgraded to Outperform from Neutral at Baird
- 01/31/23 UBS
- Cardinal Health price target raised to $91 from $78 at UBS
- 03/13/23 Piper Sandler
- Piper agrees with Icahn, says Illumina base business undervalued
- 02/14/23 UBS
- Illumina price target lowered to $240 from $255 at UBS
- 02/08/23 Stifel
- Illumina price target lowered to $235 from $285 at Stifel
- 02/08/23 RBC Capital
- Illumina price target raised to $303 from $284 at RBC Capital
- 03/28/23 Deutsche Bank
- Lyft CEO change 'opens the door' for potential buyout, says Deutsche Bank
- 03/28/23 Wedbush
- Wedbush incrementally more positive on Lyft with 'CEO changing of guard'
- 03/15/23 Deutsche Bank
- Lyft price target raised to $12 from $11 at Deutsche Bank
- 03/14/23 Jefferies
- California ruling a 'big win' for Uber, Lyft and DoorDash, says Jefferies
- 03/24/23 RBC Capital
- JPMorgan price target lowered to $132 from $150 at RBC Capital
- 03/13/23 Wells Fargo
- Wells Fargo upgrades JPMorgan on 'Goliath is Winning' theme
- 03/13/23 Wells Fargo
- JPMorgan upgraded to Overweight from Equal Weight at Wells Fargo
- 02/24/23 Morgan Stanley
- JPMorgan price target raised to $173 from $167 at Morgan Stanley
- 03/23/23 Citi
- Citi withdraws Neutral rating on First Republic
- 03/21/23 Goldman Sachs
- First Republic rating suspended at Goldman Sachs
- 03/20/23 Evercore ISI
- Evercore ISI suspends rating on First Republic in light of uncertainty
- 03/20/23 Morgan Stanley
- Morgan Stanley removes First Republic price target amid 'wide range of outcomes'
ARCT Arcturus Therapeutics - 11/14/22 Wells Fargo
- Arcturus Therapeutics resumed with an Overweight at Wells Fargo
- 11/10/22 Baird
- Arcturus Therapeutics downgraded to Underperform from Neutral at Baird
- 11/03/22 Citi
- Arcturus Therapeutics upgraded to Buy at Citi after CSL deal
- 11/03/22 Citi
- Arcturus Therapeutics upgraded to Buy from Neutral at Citi
- $13.40 /
+2.165 (+19.27%) - 02/23/23 Craig-Hallum
- Enovix price target lowered to $15 from $23 at Craig-Hallum
- 02/23/23 Piper Sandler
- Enovix price target raised to $25 from $22.50 at Piper Sandler
- 01/26/23 JPMorgan
- Enovix price target lowered to $16 from $28 at JPMorgan
- 01/23/23 Piper Sandler
- Enovix price target lowered to $22.50 from $26.50 at Piper Sandler
- 03/13/23 JPMorgan
- Kingsoft Cloud initiated with a Neutral at JPMorgan
- 01/09/23 China Renaissance
- Kingsoft Cloud downgraded to Sell from Hold at China Renaissance
- 09/07/22 Citi
- Kingsoft Cloud downgraded to Neutral from Buy at Citi
- 06/09/22 Citi
- Kingsoft Cloud price target lowered to $8.50 from $10 at Citi
- 03/06/23 Baird
- Baird starts Bluebird at Outperform, sees lovo-cel beating estimates
- 03/06/23 Baird
- Bluebird Bio initiated with an Outperform at Baird
- 12/19/22 Morgan Stanley
- FDA removing lovo-cel partial hold a positive for Bluebird, says Morgan Stanley
- 09/27/22 Morgan Stanley
- Vertex exa-cel filing timeline 'better than feared,' says Morgan Stanley
- 01/03/23 BTIG
- Sharecare named Top Pick for first half of 2023 at BTIG
- 11/11/22 Canaccord
- Sharecare price target lowered to $3 from $4 at Canaccord
- 11/11/22 Canaccord
- Sharecare price target lowered to $3 from $4 at Canaccord
- 10/19/22 BTIG
- Sharecare 'obvious beneficiary' of Elevance growth, says BTIG
- 03/29/23 Canaccord
- SomaLogic price target lowered to $5 from $6 at Canaccord
- 03/29/23 TD Cowen
- SomaLogic price target lowered to $7 from $8 at TD Cowen
- 03/29/23 Stifel
- SomaLogic price target lowered to $7 from $8 at Stifel
- 08/16/22 TD Cowen
- SomaLogic price target lowered to $9 from $11 at Cowen
- 03/29/23 Susquehanna
- Susquehanna upgrades Carnival with liquidity concerns 'effectively de-risked'
- 03/29/23 Susquehanna
- Carnival upgraded to Positive from Neutral at Susquehanna
- 03/28/23 Stifel
- Stifel believes setup for Carnival's shares is 'overly compelling'
- 03/28/23 Barclays
- Carnival price target raised to $13 from $12 at Barclays
- 03/29/23 Wells Fargo
- Hershey upgraded to Equal Weight on pricing tailwinds at Wells Fargo
- 03/29/23 Wells Fargo
- Hershey upgraded to Equal Weight from Underweight at Wells Fargo
- 03/27/23 Mizuho
- Hershey price target raised to $235 from $222 at Mizuho
- 03/23/23 Evercore ISI
- Hershey price target raised to $255 from $250 at Evercore ISI
- 03/29/23 UBS
- Foot Locker downgraded to Sell at UBS on softlines bearishness
- 03/29/23 UBS
- Foot Locker downgraded to Sell from Neutral at UBS
- 03/21/23 Deutsche Bank
- Foot Locker price target raised to $42 from $36 at Deutsche Bank
- 03/21/23 Morgan Stanley
- Morgan Stanley 'skeptical' of 'show-me' story Foot Locker's long-term targets
- 03/29/23 UBS
- Urban Outfitters downgraded to Sell at UBS on softlines bearishness
- 03/29/23 UBS
- Urban Outfitters downgraded to Sell from Neutral at UBS
- 03/02/23 Barclays
- Urban Outfitters price target raised to $29 from $27 at Barclays
- 03/01/23 Deutsche Bank
- Deutsche Bank keeps Hold rating on Urban Outfitters, raises price target to $27
- 03/29/23 UBS
- Burlington Stores downgraded to Sell at UBS on softlines bearishness
- 03/29/23 UBS
- Burlington Stores downgraded to Sell from Neutral at UBS
- 03/03/23 Deutsche Bank
- Burlington Stores price target raised to $235 from $214 at Deutsche Bank
- 03/03/23 Morgan Stanley
- Burlington Stores price target raised to $233 from $219 at Morgan Stanley
- 03/29/23 UBS
- Ross Stores downgraded to Sell at UBS on softlines bearishness
- 03/29/23 UBS
- Ross Stores downgraded to Sell from Neutral at UBS
- 03/22/23 Loop Capital
- Loop upgrades Ross Stores to Buy on steady spending, conservative outlook
- 03/22/23 Loop Capital
- Ross Stores upgraded to Buy from Hold at Loop Capital
- 03/29/23 Morgan Stanley
- Ciena downgraded to Equal Weight from Overweight at Morgan Stanley
- 03/28/23 Raymond James
- Ciena added to Analyst Current Favorites List at Raymond James
- 03/28/23 Raymond James
- Ciena upgraded to Strong Buy from Outperform at Raymond James
- 03/07/23 B. Riley
- Ciena price target raised to $72 from $69 at B. Riley
- 03/29/23 Daiwa
- Deere initiated with an Outperform at Daiwa
- 03/29/23 Daiwa
- Deere initiated with an Outperform at Daiwa
- 02/21/23 Argus
- Deere price target raised to $485 from $475 at Argus
- 02/21/23 Morgan Stanley
- Deere price target raised to $537 from $522 at Morgan Stanley
- 03/24/23 Lake Street
- Vital Farms initiated with a Buy at Lake Street
- 12/29/22 BofA
- Cal-Maine earnings miss to weigh on shares, says BofA
- 09/28/22 BofA
- Cal-Maine Foods price target lowered to $50 from $55 at BofA
- 03/30/22 Consumer Edge
- Cal-Maine Foods upgraded to Overweight from Equal Weight at Consumer Edge
- 03/29/23 Stephens
- nCino price target lowered to $27 from $33 at Stephens
- 03/29/23 Needham
- nCino price target lowered to $33 from $35 at Needham
- 03/29/23 Truist
- nCino price target lowered to $40 from $45 at Truist
- 03/29/23 BofA
- nCino price target lowered to $30 from $32 at BofA
- 03/29/23 Truist
- Dave & Buster's price target lowered to $60 from $62 at Truist
- 03/14/23 Truist
- Truist card transaction data bullish for fast-food restaurant demand
- 12/21/22 Jefferies
- Brinker downgraded to Hold from Buy at Jefferies
- 12/08/22 Loop Capital
- Dave & Buster's off to slow start in Q4, says Loop Capital
- 03/29/23 Oppenheimer
- Progress Software price target raised to $63 from $53 at Oppenheimer
- 03/13/23 Guggenheim
- Progress Software price target raised to $64 from $60 at Guggenheim
- 03/12/23 Citi
- Citi not too concerned about systems software exposure to SVB
- 01/23/23 Guggenheim
- Progress Software assumed with a Buy at Guggenheim
- 12/07/22 Stephens
- Conn's price target lowered to $9 from $13 at Stephens
- 04/11/22 Stephens
- Conn's assumed with an Equal Weight at Stephens
- 02/28/23
- Urban Outfitters reports Q4 EPS 34c, consensus 38c
- 11/21/22
- Urban Outfitters reports Q3 EPS 40c, consensus 42c
- 11/21/22
- Notable companies reporting after market close
- 01/31/23
- UBS reports Q4 EPS 50c, profit before tax $1.9B
- 10/25/22
- UBS reports Q3 EPS 52c, net profit $1.7B
- 03/02/23
- Stratasys sees FY23 EPS 12c-24c, consensus 20c
- 03/02/23
- Stratasys reports Q4 EPS 7c, consensus 3c
- 11/10/22
- Stratasys sees FY22 EPS 9c-12c, consensus 14c
- 03/28/23
- SomaLogic sees FY23 revenue $80M-$84M, consensus $92.75M
- 03/28/23
- SomaLogic reports Q4 EPS (26c), consensus (21c)
- 01/09/23
- SomaLogic sees 2022 revenue at high-end of $93M-$98M, consensus $95M
- 11/14/22
- SomaLogic sees FY22 revenue $93M-$98M, consensus $83.02M
- 03/29/23
- Sharecare sees FY23 revenue $450M-$460M, consensus $518.49M
- 03/29/23
- Sharecare sees Q1 revenue $111M-$113M, consensus $118.8M
- 03/29/23
- Sharecare reports Q4 adjusted EPS (2c), consensus (5c)
- 11/10/22
- Sharecare reports Q3 adjusted EPS (1c), consensus (6c)
- 02/28/23
- Ross Stores sees FY23 EPS $4.65-$4.95, consensus $5.09
- 02/28/23
- Ross Stores sees Q1 EPS 99c-$1.05, consensus $1.18
- 02/28/23
- Ross Stores reports Q4 EPS $1.31, consensus $1.24
- 02/28/23
- Notable companies reporting after market close
- 03/28/23
- Progress Software sees Q2 EPS 88c-92c, consensus 99c
- 03/28/23
- Progress Software backs FY23 EPS view $4.09-$4.17, consensus $4.14
- 03/28/23
- Progress Software reports Q1 EPS $1.19, consensus $1.05
- 01/17/23
- Progress Software sees FY23 EPS $4.09 - $4.17 , consensus $4.35
- 03/28/23
- Dave & Buster's reports Q4 EPS 80c, consensus 73c
- 12/06/22
- Dave & Buster's reports Q3 EPS 4c, consensus 4c
- 01/24/23
- Nano Dimension reports Q4 revenue $12.1M, up 61% vs. 4Q21
- 12/01/22
- Nano Dimension reports Q3 EPS (26c) vs. (7c) last year
- 10/24/22
- Nano Dimension sees Q3 revenue $10M
- 03/28/23
- nCino reports Q4 EPS 4c, consensus (5c)
- 01/19/23
- nCino backs FY23 EPS view of (15c)-(17c), consensus (16c)
- 01/19/23
- nCino backs Q4 EPS view of (4c)-(5c), consensus (5c)
- 11/30/22
- nCino raises FY23 EPS view to (17c)-(15c) from (19c)-(17c), consensus (17c)
- 03/28/23
- Micron sees Q3 adjusted EPS ($1.65)-($1.51), consensus (90c)
- 03/28/23
- Micron reports Q2 adjusted EPS ($1.91), consensus (86c)
- 03/28/23
- Notable companies reporting after market close
- 03/02/23
- Micron sees lower margins in fiscal Q3 than previously expected
- 03/02/23
- Macy's sees Q1 adjusted EPS 42c-48c, consensus 72c
- 03/02/23
- Macy's sees FY23 adjusted EPS $3.67-$4.11, consensus $3.84
- 03/02/23
- Macy's reports Q4 adjusted EPS $1.88, consensus $1.57
- 03/01/23
- Notable companies reporting before tomorrow's open
- 02/09/23
- Lyft reports Q4 active riders up 8.7% y/y
- 02/09/23
- Lyft sees Q1 revenue roughly $975M, consensus $1.09B
- 02/09/23
- Lyft reports Q4 adjusted EBITDA ($248.3M) vs ($47.6M) last year
- 02/09/23
- Notable companies reporting after market close
- 03/29/23
- Kingsoft Cloud sees Q1 revenue RMB1.85B-RMB2.05B
- 03/29/23
- Kingsoft Cloud reports Q4 EPS (2c), consensus (24c)
- 11/23/22
- Kingsoft Cloud sees Q4 revenue up 1.6%-11.7% sequentially to RMB2.0B-RMB2.2B
- 11/23/22
- Kingsoft Cloud reports Q3 EPS (3c), consensus (23c)
- 01/13/23
- JPMorgan reports Q4 EPS $3.57, consensus $3.07
- 01/12/23
- Notable companies reporting before tomorrow's open
- 10/14/22
- JPMorgan reports Q3 EPS $3.12, consensus $2.88
- 02/07/23
- Illumina sees FY23 adjusted EPS $1.25-$1.50, consensus $1.98
- 02/07/23
- Illumina reports Q4 adjusted EPS 14c, consensus 10c
- 02/07/23
- Notable companies reporting after market close
- 11/03/22
- Illumina sees FY22 adjusted EPS $2.35-$2.50, consensus $2.78
- 03/22/23
- Hershey backs FY23 adjusted EPS growth view 9%-11%, consensus $9.35
- 02/02/23
- Hershey sees FY23 adjusted EPS up 9%-11%, consensus $8.94
- 02/02/23
- Hershey reports Q4 adjusted EPS $2.02, consensus $1.77
- 01/13/23
- First Republic reports Q4 EPS $1.88, consensus $1.80
- 10/14/22
- First Republic reports Q3 EPS $2.21, consensus $2.18
- 03/20/23
- Foot Locker targeting adjusted EPS growth in low to mid 20% range for FY24-FY26
- 03/20/23
- Foot Locker sees FY23 adjusted EPS $3.35-$3.65, consensus $4.48
- 03/20/23
- Foot Locker reports Q4 adjusted EPS 97c, consensus 51c
- 11/18/22
- Foot Locker raises FY22 EPS view to $4.42-$4.50 from $4.25-$4.45
- $13.40 /
+2.165 (+19.27%) - 02/22/23
- Enovix reports Q EPS (19c), consensus (16c)
- 11/01/22
- Enovix sees 2022 revenue $6M-$8M, consensus $6.62M
- 11/01/22
- Enovix reports Q3 EPS (53c), consensus (16c)
- 02/17/23
- Deere sees FY23 net income $8.75B-$9.25B, effective tax rate 23%-25%
- 02/17/23
- Deere reports Q1 EPS $6.55, consensus $5.56
- 02/16/23
- Notable companies reporting before tomorrow's open
- 02/09/23
- Credit Suisse reports Q4 net revenue CHF 3.06B vs. CHF 4.58B last year
- 10/27/22
- Credit Suisse reports Q3 net revenue CHF 3.8B vs. CHF 5.43B last year
- 03/29/23
- Conn's reports Q4 adjusted EPS ($1.53), consensus (87c)
- 12/06/22
- Conn's reports Q3 non-GAAP EPS (78c), consensus (83c)
- 10/18/22
- Conn's withdraws FY23 financial guidance
- 10/18/22
- Conn's sees Q3 revenue down 21%-23%, consensus $326.11M
- 03/06/23
- Ciena now sees FY23 revenue up 20%-22% y/y, up from 16%-18% y/y
- 03/06/23
- Ciena sees Q2 revenue $1.035B-$1.115B, consensus $1.04B
- 03/06/23
- Ciena reports Q1 adjusted EPS 64c, consensus 36c
- 12/08/22
- Ciena sees Q1 revenue $910M-$990M, consensus $871.03M
- 03/27/23
- Carnival sees Q2 adjusted EBITDA $600M-$700M
- 03/27/23
- Carnival sees FY23 adjusted EBITDA $3.9B-$4.1B
- 03/27/23
- Carnival sees FY23 adjusted EPS (44c)-(28c), consensus (8c)
- 03/27/23
- Carnival sees Q2 adjusted EPS (42c)-(34c), consensus (28c)
- 03/28/23
- Cal-Maine Foods reports Q3 EPS $6.62, consensus $5.47
- 12/28/22
- Cal-Maine Foods reports Q2 EPS $4.07, consensus $4.24
- 02/02/23
- Cardinal Health raises FY23 EPS view to $5.20-$5.50 from $5.05-$5.40
- 02/02/23
- Cardinal Health reports Q2 EPS $1.32, consensus $1.14
- 02/01/23
- Notable companies reporting before tomorrow's open
- 03/02/23
- Burlington Stores sees Q1 adjusted EPS 85c-95c, consensus 82c
- 03/02/23
- Burlington Stores sees FY23 adjusted EPS $5.50-$6.00, consensus $6.65
- 03/02/23
- Burlington Stores reports Q4 adjusted EPS $2.96, consensus $2.73
- 03/29/23
- Bluebird Bio reports Q4 EPS (38c), consensus (44c)
- 11/07/22
- Bluebird Bio reports Q4 EPS (94c) vs, ($3.16)
- 11/07/22
- Bluebird Bio reports Q4 EPS (94c) vs, ($3.16)
ARCT Arcturus Therapeutics - 03/28/23
- Arcturus Therapeutics reports Q4 EPS $4.33, consensus 98c
- 11/09/22
- Arcturus Therapeutics reports Q3 EPS ($1.33), consensus ($1.81)
|
Recommendations
|
Stephens analyst Charles… Stephens analyst Charles Nabhan lowered the firm's price target on nCino to $27 from $33 and keeps an Overweight rating on the shares. While headline results for Q4 were better than expected, nCino's bookings fell short, several large deals were missed, and management noted delays in decision-making across its customer base, the analyst tells investors. In the firms view, the shortened duration and deceleration in RPO growth raises questions about the company's long-term growth outlook. ShowHide Related Items >><< - 02/28/23
- nCino selected by JFG to modernize multiple lines of business
- 02/22/23
- nCino's SimpleNexus announces Avidia Bank implemented Nexus Closing
- 02/13/23
- nCino says DOJ investigation closed, no fines or penalties imposed
- 02/07/23
- nCino expands nCino IQ offerings through partnership with rich data company
- 03/29/23 Needham
- nCino price target lowered to $33 from $35 at Needham
- 03/29/23 Truist
- nCino price target lowered to $40 from $45 at Truist
- 03/29/23 BofA
- nCino price target lowered to $30 from $32 at BofA
- 03/29/23 Barclays
- nCino price target lowered to $26 from $35 at Barclays
- 03/28/23
- nCino reports Q4 EPS 4c, consensus (5c)
- 01/19/23
- nCino backs FY23 EPS view of (15c)-(17c), consensus (16c)
- 01/19/23
- nCino backs Q4 EPS view of (4c)-(5c), consensus (5c)
- 11/30/22
- nCino raises FY23 EPS view to (17c)-(15c) from (19c)-(17c), consensus (17c)
- 03/28/23
- Fly Intel: After-Hours Movers
- 03/23/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/14/23
- What You Missed On Wall Street On Tuesday
- 03/14/23
- What You Missed On Wall Street This Morning
- 11/30/22
- nCino options imply 9.0% move in share price post-earnings
|
Recommendations
|
Needham analyst Mayank… Needham analyst Mayank Tandon lowered the firm's price target on nCino to $33 from $35 but keeps a Buy rating on the shares. The company delivered upbeat Q4 results that came in above expectations on the top and bottom line, but its bookings were soft as management cited delayed decision-making among large banks, specifically in North America, which in turn led to deals slipping, the analyst tells investors in a research note. Needham adds however that the management highlighted improving momentum within nCino's SimpleNexus despite the challenging mortgage environment, which is helping drive improved cross-selling. ShowHide Related Items >><< - 02/28/23
- nCino selected by JFG to modernize multiple lines of business
- 02/22/23
- nCino's SimpleNexus announces Avidia Bank implemented Nexus Closing
- 02/13/23
- nCino says DOJ investigation closed, no fines or penalties imposed
- 02/07/23
- nCino expands nCino IQ offerings through partnership with rich data company
- 03/29/23 Truist
- nCino price target lowered to $40 from $45 at Truist
- 03/29/23 BofA
- nCino price target lowered to $30 from $32 at BofA
- 03/29/23 Barclays
- nCino price target lowered to $26 from $35 at Barclays
- 03/24/23 Morgan Stanley
- nCino price target lowered to $27 from $35 at Morgan Stanley
- 03/28/23
- nCino reports Q4 EPS 4c, consensus (5c)
- 01/19/23
- nCino backs FY23 EPS view of (15c)-(17c), consensus (16c)
- 01/19/23
- nCino backs Q4 EPS view of (4c)-(5c), consensus (5c)
- 11/30/22
- nCino raises FY23 EPS view to (17c)-(15c) from (19c)-(17c), consensus (17c)
- 03/28/23
- Fly Intel: After-Hours Movers
- 03/23/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/14/23
- What You Missed On Wall Street On Tuesday
- 03/14/23
- What You Missed On Wall Street This Morning
- 11/30/22
- nCino options imply 9.0% move in share price post-earnings
|
Recommendations
|
Truist analyst Terry… Truist analyst Terry Tillman lowered the firm's price target on nCino to $40 from $45 but keeps a Buy rating on the shares. The company's Q4 results were "relatively solid", but its bookings were below management's expectations owing to longer deal cycles, more deal scrutiny, and higher than expected churn rate, the analyst tells investors in a research note. Truist adds however that while the the changing macro and banking landscape is worth monitoring, the firm is positive on the company's 95% visibility into the high end of its sub revenue guidance for the year. ShowHide Related Items >><< - 02/28/23
- nCino selected by JFG to modernize multiple lines of business
- 02/22/23
- nCino's SimpleNexus announces Avidia Bank implemented Nexus Closing
- 02/13/23
- nCino says DOJ investigation closed, no fines or penalties imposed
- 02/07/23
- nCino expands nCino IQ offerings through partnership with rich data company
- 03/29/23 BofA
- nCino price target lowered to $30 from $32 at BofA
- 03/29/23 Barclays
- nCino price target lowered to $26 from $35 at Barclays
- 03/24/23 Morgan Stanley
- nCino price target lowered to $27 from $35 at Morgan Stanley
- 03/23/23 KeyBanc
- nCino downgraded on extended sales cycles at KeyBanc
- 03/28/23
- nCino reports Q4 EPS 4c, consensus (5c)
- 01/19/23
- nCino backs FY23 EPS view of (15c)-(17c), consensus (16c)
- 01/19/23
- nCino backs Q4 EPS view of (4c)-(5c), consensus (5c)
- 11/30/22
- nCino raises FY23 EPS view to (17c)-(15c) from (19c)-(17c), consensus (17c)
- 03/28/23
- Fly Intel: After-Hours Movers
- 03/23/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/14/23
- What You Missed On Wall Street On Tuesday
- 03/14/23
- What You Missed On Wall Street This Morning
- 11/30/22
- nCino options imply 9.0% move in share price post-earnings
|
Recommendations
|
BofA analyst Brad Sills… BofA analyst Brad Sills lowered the firm's price target on nCino to $30 from $32 and keeps a Buy rating on the shares. The company reported "solid" Q4 results and FY24 guidance and pipeline commentary "likely came in better than expected for many investors given the ongoing events in the US banking sector," the analyst said. The firm tweaked its estimates and target to reflect the updated guidance. ShowHide Related Items >><< - 02/28/23
- nCino selected by JFG to modernize multiple lines of business
- 02/22/23
- nCino's SimpleNexus announces Avidia Bank implemented Nexus Closing
- 02/13/23
- nCino says DOJ investigation closed, no fines or penalties imposed
- 02/07/23
- nCino expands nCino IQ offerings through partnership with rich data company
- 03/29/23 Barclays
- nCino price target lowered to $26 from $35 at Barclays
- 03/24/23 Morgan Stanley
- nCino price target lowered to $27 from $35 at Morgan Stanley
- 03/23/23 KeyBanc
- nCino downgraded on extended sales cycles at KeyBanc
- 03/22/23 KeyBanc
- nCino downgraded to Sector Weight from Overweight at KeyBanc
- 03/28/23
- nCino reports Q4 EPS 4c, consensus (5c)
- 01/19/23
- nCino backs FY23 EPS view of (15c)-(17c), consensus (16c)
- 01/19/23
- nCino backs Q4 EPS view of (4c)-(5c), consensus (5c)
- 11/30/22
- nCino raises FY23 EPS view to (17c)-(15c) from (19c)-(17c), consensus (17c)
- 03/28/23
- Fly Intel: After-Hours Movers
- 03/23/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/14/23
- What You Missed On Wall Street On Tuesday
- 03/14/23
- What You Missed On Wall Street This Morning
- 11/30/22
- nCino options imply 9.0% move in share price post-earnings
|